Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)

Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825) Article

Wefel, Jeffrey S, Armstrong, Terri S, Pugh, Stephanie L et al. (2021). Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825) . NEURO-ONCOLOGY, 23(7), 1125-1138. 10.1093/neuonc/noab011

Open Access

cited authors

Wefel, Jeffrey S; Armstrong, Terri S; Pugh, Stephanie L; Gilbert, Mark R; Wendland, Merideth M; Brachman, David G; Roof, Kevin S; Brown, Paul D; Crocker, Ian R; Robins, H Ian; Hunter, Grant; Won, Minhee; Mehta, Minesh P

sustainable development goals

SDG 03: Good Health and Well-being

authors

Mehta, Minesh

publication date

January 29, 2021

webpage

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715361700012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=e451fd656366bf1ec5554941920a9ccb

published in

NEURO-ONCOLOGY Journal

keywords

ADJUVANT TEMOZOLOMIDE
Clinical Neurology
Life Sciences & Biomedicine
NORMATIVE DATA
Neurosciences & Neurology
Oncology
Science & Technology
glioma
neurocognitive function
patient-reported outcome

FIU Discovery

Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825) Article

Overview

cited authors

sustainable development goals

authors

publication date

webpage

published in

Research

keywords

Identifiers

Digital Object Identifier (DOI)

Additional Document Info

publisher

start page

end page

volume

issue